Medicare and Medicaid Programs; Application From DNV GL Healthcare USA Inc. for Initial CMS Approval of Its Psychiatric Hospital Accreditation Program, 45639-45640 [2020-16453]
Download as PDF
Federal Register / Vol. 85, No. 146 / Wednesday, July 29, 2020 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3388–FN]
Medicare and Medicaid Programs;
Application From DNV GL Healthcare
USA Inc. for Initial CMS Approval of Its
Psychiatric Hospital Accreditation
Program
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Final notice.
AGENCY:
This final notice announces
our decision to approve DNV GL
Healthcare USA Inc. (DNV GL) for
initial recognition as a national
accrediting organization for psychiatric
hospitals that wish to participate in the
Medicare or Medicaid programs.
DATES: The decision announced in this
final notice is effective July 30, 2020
through July 30, 2024.
FOR FURTHER INFORMATION CONTACT:
Joann Fitzell, (410) 786–4280. Lillian
Williams, (410) 786–8636.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background
Under the Medicare program, eligible
beneficiaries may receive covered
services from a psychiatric hospital
provided certain requirements
established by the Secretary of the
Department of Health and Human
Services (the Secretary) are met. Section
1861(f) of the Social Security Act (the
Act) establishes distinct criteria for
facilities seeking designation as a
psychiatric hospital under Medicare.
Regulations concerning provider
agreements and supplier approval are at
42 CFR part 489 and those pertaining to
activities relating to the survey and
certification of facilities are at 42 CFR
part 488. The regulations at 42 CFR part
482 subparts A, B, C and E specify the
minimum conditions that a psychiatric
hospital must meet to participate in the
Medicare program, the scope of covered
services and the conditions for Medicare
payment for psychiatric hospitals.
Generally, to enter into a provider
agreement with the Medicare program, a
psychiatric hospital must first be
certified by a state survey agency as
complying with the conditions or
requirements set forth in part 482
subpart A, B, C and E of Centers for
Medicare & Medicaid Services (CMS)
regulations. Thereafter, the psychiatric
hospital is subject to regular surveys by
a state survey agency to determine
whether it continues to meet the
Medicare requirements.
VerDate Sep<11>2014
17:23 Jul 28, 2020
Jkt 250001
However, there is an alternative to
surveys by state agencies. Section
1865(a)(1) of the Act states, if a provider
entity demonstrates through
accreditation by an approved national
accrediting organization (AO) that all
applicable Medicare conditions are met
or exceeded, we may treat the provider
entity as having met those conditions,
that is, we may deem the provider entity
as having met the requirements.
Accreditation by an AO is voluntary and
is not required for Medicare
participation.
If an AO is recognized by CMS as
having standards for accreditation that
meet or exceed Medicare requirements,
any provider entity accredited by the
national accrediting body’s approved
program may be deemed to meet the
Medicare conditions. A national AO
applying for approval of its
accreditation program under part 488,
subpart A, must provide CMS with
reasonable assurance that the AO
requires the accredited provider entities
to meet requirements that are at least as
stringent as the Medicare conditions.
Our regulations concerning the approval
of AOs are set forth at § 488.5. The
regulations at § 488.5(e)(2)(i) require the
AO to reapply for continued approval of
its accreditation program every 6 years
or sooner as determined by CMS.
II. Application Approval Process
Section 1865(a)(2) of the Act and our
regulations at § 488.5 require that
findings concerning review and
approval of an AO’s requirements
consider, among other factors, the
applying AO’s requirements for
accreditation; survey procedures;
resources for conducting required
surveys; capacity to furnish information
for use in enforcement activities;
monitoring procedures for provider
entities that were found not in
compliance with the conditions or
requirements; and ability to provide
CMS with the necessary data for
validation.
Section 1865(a)(3)(A) of the Act
provides a statutory timetable to ensure
that our review of applications for CMSapproval of an accreditation program is
conducted in a timely manner. The Act
provides CMS 210 days after the date of
receipt of a complete application, with
any documentation necessary to make
the determination, to complete our
survey activities and application
process. Within 60 days after receiving
a complete application, CMS must
publish a notice in the Federal Register
that identifies the national accrediting
body making the request, describes the
request, and provides no less than a 30day public comment period. At the end
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
45639
of the 210-day period, CMS must
publish a notice in the Federal Register
approving or denying the application.
III. Provisions of the Proposed Notice
On March 2, 2020 Federal Register
(85 FR 12306), we published a proposed
notice announcing DNV GL Healthcare
USA Inc. (DNV GL) request for approval
of its Medicare psychiatric hospital
accreditation program. In the proposed
notice, we detailed our evaluation
criteria. Under section 1865(a)(2) of the
Act and in our regulations at § 488.5, we
conducted a review of DNV GL’s
Medicare psychiatric hospital
accreditation application in accordance
with the criteria specified by our
regulations, which include, but are not
limited to the following:
• An onsite administrative review of
DNV GL’s: (1) Corporate policies; (2)
financial and human resources available
to accomplish the proposed surveys; (3)
procedures for training, monitoring, and
evaluation of its psychiatric hospital
surveyors; (4) ability to investigate and
respond appropriately to complaints
against accredited psychiatric hospitals;
and, (5) survey review and decisionmaking process for accreditation.
• The comparison of DNV GL’s
Medicare psychiatric hospital
accreditation program standards to our
current Medicare hospitals Conditions
of Participation (CoPs) and psychiatric
hospital special CoPs.
• A documentation review of DNV
GL’s psychiatric hospital survey process
to do the following:
++ Determine the composition of the
survey team, surveyor qualifications,
and DNV GL’s ability to provide
continuing surveyor training.
++ Compare DNV GL’s processes to
those we require of state survey
agencies, including periodic re-survey
and the ability to investigate and
respond appropriately to complaints
against accredited psychiatric hospitals.
++ Evaluate DNV GL’s procedures for
monitoring psychiatric hospitals it has
found to be out of compliance with DNV
GL’s program requirements. (This
pertains only to monitoring procedures
when DNV GL identifies as noncompliance. If noncompliance is
identified by a state survey agency
through a validation survey, the state
survey agency monitors corrections as
specified at § 488.9(c)(1)).
++ Assess DNV GL’s ability to report
deficiencies to the surveyed hospital
and respond to the psychiatric
hospital’s plan of correction in a timely
manner.
++ Establish DNV GL’s ability to
provide CMS with electronic data and
reports necessary for effective validation
E:\FR\FM\29JYN1.SGM
29JYN1
45640
Federal Register / Vol. 85, No. 146 / Wednesday, July 29, 2020 / Notices
and assessment of the organization’s
survey process.
++ Determine the adequacy of DNV
GL’s staff and other resources.
++ Confirm DNV GL’s ability to
provide adequate funding for
performing required surveys.
++ Confirm DNV GL’s policies with
respect to surveys being unannounced.
++ Confirm DNV GL’s policies and
procedures to avoid conflicts of interest,
including the appearance of conflicts of
interest, involving individuals who
conduct surveys or participate in
accreditation decisions.
++ Obtain DNV GL’s agreement to
provide CMS with a copy of the most
current accreditation survey together
with any other information related to
the survey as we may require, including
corrective action plans.
++ As authorized under § 488.8(h),
CMS reserves the right to conduct onsite
observations of accrediting
organization’s operations at any time as
part of the ongoing review and
continuing oversight of an AO’s
performance.
In accordance with section
1865(a)(3)(A) of the Act, the March 2,
2020 proposed notice also solicited
public comments regarding whether
DNV GL’s requirements met or exceeded
the Medicare CoPs for psychiatric
hospitals. We received 4 comments in
response to our proposed notice. We
thank the commenters for their support.
We agreed with the commenters that a
new psychiatric hospital accreditation
organization would provide hospitals
further options in regards to
accreditation. Based on our
comprehensive review of their program,
we have approved DNV GL as such a
program.
IV. Provisions of the Final Notice
A. Differences Between DNV GL’s
Standards and Requirements for
Accreditation and Medicare Conditions
and Survey Requirements
We compared DNV GL’s psychiatric
hospital accreditation program
requirements and survey process with
the Medicare CoPs at 42 CFR part 482,
and the survey and certification process
requirements of parts 488 and 489. Our
review and evaluation of DNV GL’s
psychiatric hospital application, which
were conducted as described in section
III of this final notice, yielded the
following areas where, as of the date of
this notice, DNV GL has revised its
standards and certification processes in
order to meet the requirements at:
• Section 482.41(c)(1): DNV GL
revised its standards to not require the
hospitals to adopt Chapters 7, 8, 12, and
VerDate Sep<11>2014
17:23 Jul 28, 2020
Jkt 250001
13 of the adopted Health Care Facilities
Code.
• Section 482.61(a) through (a)(3):
DNV GL revised its standards to require
a diagnosis for all patients.
• Section 482.61(b): DNV GL revised
its standards to require a record of
mental status.
• State Operations Manual Chapter 3
Section 3012: DNV GL revised its
materials to reflect its timeframe(s) for
follow-up activities, including followup surveys for facilities that have
previously demonstrated noncompliance at the condition level.
• Section 488.5(a)(12): DNV GL
revised its policies to ensure a clearly
defined complaint investigation process
is in place that meets the requirements
in the State Operations Manual Chapter
5 Section 5010 and Chapter 5 Section
5075.2 that includes the following:
++ Complete and accurate tracking of
complaints as well as a process for
maintaining a documented record of
contacts made (for example, phone,
email and United States mail) with the
complainant, and others, if applicable.
++ Defining the number of contact
attempts required before closing out a
complaint if the complainant does not
respond.
++ Educating DNV GL complaint
intake staff that when complaint
allegations could potentially result in
condition-level non-compliance
affecting the health and safety of
patients, a survey is to be considered
regardless if the allegation also involves
payment related allegations.
++ Investigating complaints onsite
within an appropriate timeframe.
B. Term of Approval
Based on our review and observations
described in section III of this final
notice, we have determined that DNV
GL’s psychiatric hospital accreditation
program requirements meet or exceed
our requirements, and its survey
processes are also comparable.
Therefore, we approve DNV GL as a
national AO for psychiatric hospitals
that request participation in the
Medicare program, effective July 30,
2020 through July 30, 2024.
V. Collection of Information
Requirements
This document does not impose
information collection requirements,
that is, reporting, recordkeeping or
third-party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
The Administrator of the Centers for
Medicare & Medicaid Services (CMS),
Seema Verma, having reviewed and
approved this document, authorizes
Lynette Wilson, who is the Federal
Register Liaison, to electronically sign
this document for purposes of
publication in the Federal Register.
Dated: July 24, 2020.
Lynette Wilson,
Federal Register Liaison, Department of
Health and Human Services.
[FR Doc. 2020–16453 Filed 7–28–20; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2018–D–1339]
Multiple Function Device Products:
Policy and Considerations; Guidance
for Industry and Food and Drug
Administration Staff; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a final
guidance entitled ‘‘Multiple Function
Device Products: Policy and
Considerations; Guidance for Industry
and Food and Drug Administration
Staff.’’ This final guidance provides
FDA’s regulatory approach for device
products with multiple functions
including at least one device function
and includes such device products that
are part of combination products, in
accordance with the 21st Century Cures
Act (Cures Act).
DATES: The announcement of the
guidance is published in the Federal
Register on July 29, 2020.
ADDRESSES: You may submit either
electronic or written comments on
Agency guidances at any time as
follows:
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
E:\FR\FM\29JYN1.SGM
29JYN1
Agencies
[Federal Register Volume 85, Number 146 (Wednesday, July 29, 2020)]
[Notices]
[Pages 45639-45640]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-16453]
[[Page 45639]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3388-FN]
Medicare and Medicaid Programs; Application From DNV GL
Healthcare USA Inc. for Initial CMS Approval of Its Psychiatric
Hospital Accreditation Program
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Final notice.
-----------------------------------------------------------------------
SUMMARY: This final notice announces our decision to approve DNV GL
Healthcare USA Inc. (DNV GL) for initial recognition as a national
accrediting organization for psychiatric hospitals that wish to
participate in the Medicare or Medicaid programs.
DATES: The decision announced in this final notice is effective July
30, 2020 through July 30, 2024.
FOR FURTHER INFORMATION CONTACT: Joann Fitzell, (410) 786-4280.
Lillian Williams, (410) 786-8636.
SUPPLEMENTARY INFORMATION:
I. Background
Under the Medicare program, eligible beneficiaries may receive
covered services from a psychiatric hospital provided certain
requirements established by the Secretary of the Department of Health
and Human Services (the Secretary) are met. Section 1861(f) of the
Social Security Act (the Act) establishes distinct criteria for
facilities seeking designation as a psychiatric hospital under
Medicare. Regulations concerning provider agreements and supplier
approval are at 42 CFR part 489 and those pertaining to activities
relating to the survey and certification of facilities are at 42 CFR
part 488. The regulations at 42 CFR part 482 subparts A, B, C and E
specify the minimum conditions that a psychiatric hospital must meet to
participate in the Medicare program, the scope of covered services and
the conditions for Medicare payment for psychiatric hospitals.
Generally, to enter into a provider agreement with the Medicare
program, a psychiatric hospital must first be certified by a state
survey agency as complying with the conditions or requirements set
forth in part 482 subpart A, B, C and E of Centers for Medicare &
Medicaid Services (CMS) regulations. Thereafter, the psychiatric
hospital is subject to regular surveys by a state survey agency to
determine whether it continues to meet the Medicare requirements.
However, there is an alternative to surveys by state agencies.
Section 1865(a)(1) of the Act states, if a provider entity demonstrates
through accreditation by an approved national accrediting organization
(AO) that all applicable Medicare conditions are met or exceeded, we
may treat the provider entity as having met those conditions, that is,
we may deem the provider entity as having met the requirements.
Accreditation by an AO is voluntary and is not required for Medicare
participation.
If an AO is recognized by CMS as having standards for accreditation
that meet or exceed Medicare requirements, any provider entity
accredited by the national accrediting body's approved program may be
deemed to meet the Medicare conditions. A national AO applying for
approval of its accreditation program under part 488, subpart A, must
provide CMS with reasonable assurance that the AO requires the
accredited provider entities to meet requirements that are at least as
stringent as the Medicare conditions. Our regulations concerning the
approval of AOs are set forth at Sec. 488.5. The regulations at Sec.
488.5(e)(2)(i) require the AO to reapply for continued approval of its
accreditation program every 6 years or sooner as determined by CMS.
II. Application Approval Process
Section 1865(a)(2) of the Act and our regulations at Sec. 488.5
require that findings concerning review and approval of an AO's
requirements consider, among other factors, the applying AO's
requirements for accreditation; survey procedures; resources for
conducting required surveys; capacity to furnish information for use in
enforcement activities; monitoring procedures for provider entities
that were found not in compliance with the conditions or requirements;
and ability to provide CMS with the necessary data for validation.
Section 1865(a)(3)(A) of the Act provides a statutory timetable to
ensure that our review of applications for CMS-approval of an
accreditation program is conducted in a timely manner. The Act provides
CMS 210 days after the date of receipt of a complete application, with
any documentation necessary to make the determination, to complete our
survey activities and application process. Within 60 days after
receiving a complete application, CMS must publish a notice in the
Federal Register that identifies the national accrediting body making
the request, describes the request, and provides no less than a 30-day
public comment period. At the end of the 210-day period, CMS must
publish a notice in the Federal Register approving or denying the
application.
III. Provisions of the Proposed Notice
On March 2, 2020 Federal Register (85 FR 12306), we published a
proposed notice announcing DNV GL Healthcare USA Inc. (DNV GL) request
for approval of its Medicare psychiatric hospital accreditation
program. In the proposed notice, we detailed our evaluation criteria.
Under section 1865(a)(2) of the Act and in our regulations at Sec.
488.5, we conducted a review of DNV GL's Medicare psychiatric hospital
accreditation application in accordance with the criteria specified by
our regulations, which include, but are not limited to the following:
An onsite administrative review of DNV GL's: (1) Corporate
policies; (2) financial and human resources available to accomplish the
proposed surveys; (3) procedures for training, monitoring, and
evaluation of its psychiatric hospital surveyors; (4) ability to
investigate and respond appropriately to complaints against accredited
psychiatric hospitals; and, (5) survey review and decision-making
process for accreditation.
The comparison of DNV GL's Medicare psychiatric hospital
accreditation program standards to our current Medicare hospitals
Conditions of Participation (CoPs) and psychiatric hospital special
CoPs.
A documentation review of DNV GL's psychiatric hospital
survey process to do the following:
++ Determine the composition of the survey team, surveyor
qualifications, and DNV GL's ability to provide continuing surveyor
training.
++ Compare DNV GL's processes to those we require of state survey
agencies, including periodic re-survey and the ability to investigate
and respond appropriately to complaints against accredited psychiatric
hospitals.
++ Evaluate DNV GL's procedures for monitoring psychiatric
hospitals it has found to be out of compliance with DNV GL's program
requirements. (This pertains only to monitoring procedures when DNV GL
identifies as non-compliance. If noncompliance is identified by a state
survey agency through a validation survey, the state survey agency
monitors corrections as specified at Sec. 488.9(c)(1)).
++ Assess DNV GL's ability to report deficiencies to the surveyed
hospital and respond to the psychiatric hospital's plan of correction
in a timely manner.
++ Establish DNV GL's ability to provide CMS with electronic data
and reports necessary for effective validation
[[Page 45640]]
and assessment of the organization's survey process.
++ Determine the adequacy of DNV GL's staff and other resources.
++ Confirm DNV GL's ability to provide adequate funding for
performing required surveys.
++ Confirm DNV GL's policies with respect to surveys being
unannounced.
++ Confirm DNV GL's policies and procedures to avoid conflicts of
interest, including the appearance of conflicts of interest, involving
individuals who conduct surveys or participate in accreditation
decisions.
++ Obtain DNV GL's agreement to provide CMS with a copy of the most
current accreditation survey together with any other information
related to the survey as we may require, including corrective action
plans.
++ As authorized under Sec. 488.8(h), CMS reserves the right to
conduct onsite observations of accrediting organization's operations at
any time as part of the ongoing review and continuing oversight of an
AO's performance.
In accordance with section 1865(a)(3)(A) of the Act, the March 2,
2020 proposed notice also solicited public comments regarding whether
DNV GL's requirements met or exceeded the Medicare CoPs for psychiatric
hospitals. We received 4 comments in response to our proposed notice.
We thank the commenters for their support. We agreed with the
commenters that a new psychiatric hospital accreditation organization
would provide hospitals further options in regards to accreditation.
Based on our comprehensive review of their program, we have approved
DNV GL as such a program.
IV. Provisions of the Final Notice
A. Differences Between DNV GL's Standards and Requirements for
Accreditation and Medicare Conditions and Survey Requirements
We compared DNV GL's psychiatric hospital accreditation program
requirements and survey process with the Medicare CoPs at 42 CFR part
482, and the survey and certification process requirements of parts 488
and 489. Our review and evaluation of DNV GL's psychiatric hospital
application, which were conducted as described in section III of this
final notice, yielded the following areas where, as of the date of this
notice, DNV GL has revised its standards and certification processes in
order to meet the requirements at:
Section 482.41(c)(1): DNV GL revised its standards to not
require the hospitals to adopt Chapters 7, 8, 12, and 13 of the adopted
Health Care Facilities Code.
Section 482.61(a) through (a)(3): DNV GL revised its
standards to require a diagnosis for all patients.
Section 482.61(b): DNV GL revised its standards to require
a record of mental status.
State Operations Manual Chapter 3 Section 3012: DNV GL
revised its materials to reflect its timeframe(s) for follow-up
activities, including follow-up surveys for facilities that have
previously demonstrated non-compliance at the condition level.
Section 488.5(a)(12): DNV GL revised its policies to
ensure a clearly defined complaint investigation process is in place
that meets the requirements in the State Operations Manual Chapter 5
Section 5010 and Chapter 5 Section 5075.2 that includes the following:
++ Complete and accurate tracking of complaints as well as a
process for maintaining a documented record of contacts made (for
example, phone, email and United States mail) with the complainant, and
others, if applicable.
++ Defining the number of contact attempts required before closing
out a complaint if the complainant does not respond.
++ Educating DNV GL complaint intake staff that when complaint
allegations could potentially result in condition-level non-compliance
affecting the health and safety of patients, a survey is to be
considered regardless if the allegation also involves payment related
allegations.
++ Investigating complaints onsite within an appropriate timeframe.
B. Term of Approval
Based on our review and observations described in section III of
this final notice, we have determined that DNV GL's psychiatric
hospital accreditation program requirements meet or exceed our
requirements, and its survey processes are also comparable. Therefore,
we approve DNV GL as a national AO for psychiatric hospitals that
request participation in the Medicare program, effective July 30, 2020
through July 30, 2024.
V. Collection of Information Requirements
This document does not impose information collection requirements,
that is, reporting, recordkeeping or third-party disclosure
requirements. Consequently, there is no need for review by the Office
of Management and Budget under the authority of the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501 et seq.).
The Administrator of the Centers for Medicare & Medicaid Services
(CMS), Seema Verma, having reviewed and approved this document,
authorizes Lynette Wilson, who is the Federal Register Liaison, to
electronically sign this document for purposes of publication in the
Federal Register.
Dated: July 24, 2020.
Lynette Wilson,
Federal Register Liaison, Department of Health and Human Services.
[FR Doc. 2020-16453 Filed 7-28-20; 8:45 am]
BILLING CODE 4120-01-P